ES456039A1 - Procedimiento para preparar derivados de indolizina. - Google Patents
Procedimiento para preparar derivados de indolizina.Info
- Publication number
- ES456039A1 ES456039A1 ES456039A ES456039A ES456039A1 ES 456039 A1 ES456039 A1 ES 456039A1 ES 456039 A ES456039 A ES 456039A ES 456039 A ES456039 A ES 456039A ES 456039 A1 ES456039 A1 ES 456039A1
- Authority
- ES
- Spain
- Prior art keywords
- mono
- methyl
- radical
- phenyl radical
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
Procedimiento para preparar derivados de indolizina, de fórmula general: **(Fórmula)** y sus sales de adición de ácido farmaceuticamente aceptables, por ejemplo el oxalato, hidrocloruro o metanosulfonato, en cuya fórmula R es un radical alquilo de cadena recta o ramificada con 1 a 5 átomos de carbono, un radical fenilo, un radical monofluor, monocloro- o monobromo-fenilo, un radical difluor-dicloro- ó dibromo-fenilo, un radical metoxifenilo o un radical metilfenilo sustituido opcionalmente en la mitad aromática por un átomo de fluor, cloro o bromo, y R1 y R2, que son diferentes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6680/76A GB1518443A (en) | 1976-02-19 | 1976-02-19 | Indolizine derivatives and process for preparing the same |
GB3331476 | 1976-08-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES456039A1 true ES456039A1 (es) | 1978-05-16 |
Family
ID=26240878
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES456039A Expired ES456039A1 (es) | 1976-02-19 | 1977-02-18 | Procedimiento para preparar derivados de indolizina. |
ES467441A Expired ES467441A1 (es) | 1976-02-19 | 1978-03-01 | Procedimiento para preparar derivados de indolizina. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES467441A Expired ES467441A1 (es) | 1976-02-19 | 1978-03-01 | Procedimiento para preparar derivados de indolizina. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4103012A (es) |
JP (1) | JPS52125193A (es) |
AR (2) | AR211887A1 (es) |
AT (1) | AT358035B (es) |
AU (1) | AU505894B2 (es) |
CA (1) | CA1071198A (es) |
CH (2) | CH617697A5 (es) |
DE (1) | DE2707048C2 (es) |
DK (1) | DK142622B (es) |
ES (2) | ES456039A1 (es) |
FI (1) | FI61030C (es) |
FR (1) | FR2341578A1 (es) |
GR (1) | GR59328B (es) |
IE (1) | IE44941B1 (es) |
IT (1) | IT1085862B (es) |
NL (1) | NL164283C (es) |
NO (1) | NO145842C (es) |
NZ (1) | NZ183377A (es) |
OA (1) | OA05575A (es) |
PT (1) | PT66199B (es) |
SE (1) | SE420314B (es) |
YU (3) | YU39489B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ193926A (en) * | 1979-07-06 | 1984-05-31 | Labaz Sanofi Nv | 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines |
US4378362A (en) * | 1979-12-06 | 1983-03-29 | S.A. Labaz N.V. | Indolizine derivatives and process for preparing the same |
FR2495616A1 (fr) * | 1980-12-09 | 1982-06-11 | Labaz Nv | Nouveaux derives d'indolizine, leur procede de preparation ainsi que leurs applications en therapeutique |
US4520026A (en) * | 1981-02-06 | 1985-05-28 | S. A. Labaz N.V. | Indolizine derivatives and use as cardiovascular agents |
FR2528845A1 (fr) * | 1982-06-17 | 1983-12-23 | Sanofi Sa | Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant |
JPS59113802U (ja) * | 1983-01-14 | 1984-08-01 | オムロン株式会社 | 制御装置 |
FR2594438B1 (fr) * | 1986-02-14 | 1990-01-26 | Labaz Sanofi Nv | Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant |
US5215988A (en) * | 1986-02-14 | 1993-06-01 | Sanofi | Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
NZ221717A (en) * | 1986-09-10 | 1990-08-28 | Sandoz Ltd | Azaindole and indolizine derivatives and pharmaceutical compositions |
IL87181A (en) * | 1987-08-07 | 1993-08-18 | Sanofi Sa | Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them |
US4880824A (en) * | 1987-09-21 | 1989-11-14 | Ortho Pharmaceutical Corporation | Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers |
FR2642756B1 (fr) * | 1989-02-07 | 1994-03-04 | Sanofi | Derives cycloaminoalkoxyphenyle, leur procede de preparation ainsi que les compositions pharmaceutiques ou veterinaires en contenant |
FR2642755B1 (es) * | 1989-02-07 | 1993-11-05 | Sanofi | |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
FR2893616B1 (fr) * | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
FR2967412B1 (fr) | 2010-11-17 | 2012-12-14 | Sanofi Aventis | Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique |
CN110283167A (zh) * | 2018-11-14 | 2019-09-27 | 贵州省中国科学院天然产物化学重点实验室 | 一种抗心率失常药物布托普洛嗪的制备方法 |
-
1977
- 1977-01-31 FI FI770318A patent/FI61030C/fi not_active IP Right Cessation
- 1977-02-02 GR GR52693A patent/GR59328B/el unknown
- 1977-02-11 AT AT92077A patent/AT358035B/de not_active IP Right Cessation
- 1977-02-14 CH CH180877A patent/CH617697A5/fr not_active IP Right Cessation
- 1977-02-15 FR FR7704171A patent/FR2341578A1/fr active Granted
- 1977-02-16 PT PT66199A patent/PT66199B/pt unknown
- 1977-02-16 US US05/769,332 patent/US4103012A/en not_active Expired - Lifetime
- 1977-02-17 YU YU428/77A patent/YU39489B/xx unknown
- 1977-02-17 SE SE7701771A patent/SE420314B/xx not_active IP Right Cessation
- 1977-02-17 NL NL7701678.A patent/NL164283C/xx not_active IP Right Cessation
- 1977-02-17 AU AU22394/77A patent/AU505894B2/en not_active Expired
- 1977-02-18 DE DE2707048A patent/DE2707048C2/de not_active Expired
- 1977-02-18 NO NO770547A patent/NO145842C/no unknown
- 1977-02-18 IE IE361/77A patent/IE44941B1/en unknown
- 1977-02-18 NZ NZ183377A patent/NZ183377A/xx unknown
- 1977-02-18 CA CA272,103A patent/CA1071198A/en not_active Expired
- 1977-02-18 JP JP1768977A patent/JPS52125193A/ja active Granted
- 1977-02-18 ES ES456039A patent/ES456039A1/es not_active Expired
- 1977-02-18 IT IT20434/77A patent/IT1085862B/it active
- 1977-02-18 AR AR266608A patent/AR211887A1/es active
- 1977-02-18 DK DK72677AA patent/DK142622B/da not_active IP Right Cessation
- 1977-02-19 OA OA56077A patent/OA05575A/xx unknown
- 1977-11-30 AR AR270182A patent/AR212791A1/es active
-
1978
- 1978-03-01 ES ES467441A patent/ES467441A1/es not_active Expired
-
1979
- 1979-11-30 CH CH1068079A patent/CH623322A5/fr not_active IP Right Cessation
-
1982
- 1982-08-23 YU YU1890/82A patent/YU42791B/xx unknown
-
1983
- 1983-11-16 YU YU2251/83A patent/YU42888B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES467441A1 (es) | Procedimiento para preparar derivados de indolizina. | |
ES465047A1 (es) | Procedimiento para preparar derivados de piperazina | |
IE811085L (en) | Pyridoxine derivatives | |
IE822410L (en) | Substituted azetidinols | |
ES486824A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas | |
ES462700A1 (es) | Procedimiento para la preparacion de nuevas 1h-pirazolo(3,4-b)piridinas. | |
ATE168113T1 (de) | Antiallergische, entzündungshemmende und anti-paf pyridazinverbindungen | |
ES469900A1 (es) | Un procedimiento para la preparacion de derivados de m-feno-xibenzamida | |
SE7605361L (sv) | Sett att framstella nya n-substituerade fenylpiperazinderivat | |
ES437423A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas. | |
IE822330L (en) | 2,2-disubstituted-ethylamines | |
AU626095B2 (en) | Hydroxyalkane carboxylic acid derivatives, their production and use | |
IE46097L (en) | BENZO (b) THIOPHENE | |
ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
ES468585A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas. | |
ES8401761A1 (es) | Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos. | |
ES8105981A1 (es) | Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina | |
ES448696A1 (es) | Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas. | |
IE792067L (en) | Azatricyclic compounds | |
GR72839B (es) | ||
ES444384A1 (es) | Procedimiento de preparacion de nuevas biguadinas. | |
TH9137EX (th) | สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19990503 |